Marina Paini
Overview
Explore the profile of Marina Paini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ammendola S, Girolami I, Bovo C, Paini M, Castelli C, Bruno C, et al.
Am J Case Rep
. 2020 Apr;
21:e920933.
PMID: 32273492
BACKGROUND The complications of fine-needle aspiration cytology (FNAC) are rare but can be challenging for performing physicians to diagnose and manage. This type of procedure is perceived as routine and...
2.
Scopelliti F, Pea A, Conigliaro R, Butturini G, Frigerio I, Regi P, et al.
Surg Endosc
. 2018 May;
32(9):4022-4028.
PMID: 29766302
Background And Aims: Radiofrequency ablation (RFA) is a well-recognized local ablative technique applied in the treatment of different solid tumors. Intraoperative RFA has been used for non-metastatic unresectable pancreatic ductal...
3.
Marchegiani G, Ballarin R, Malleo G, Andrianello S, Allegrini V, Pulvirenti A, et al.
World J Surg
. 2017 Jun;
41(11):2876-2883.
PMID: 28608016
Background: Pancreatic texture is one of the key predictors of postoperative pancreatic fistula (POPF) after pancreatoduodenectomy (PD). Currently, the "gold standard" for assessment of pancreatic texture is surgeon's subjective evaluation...
4.
Paini M, Crippa S, Scopelliti F, Baldoni A, Manzoni A, Belfiori G, et al.
Gastroenterol Res Pract
. 2014 Oct;
2014:269803.
PMID: 25276122
Appropriate surgical strategies for management of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are a matter of debate. Preoperative and intraoperative evaluation of malignant potential of IPMN and of...
5.
Paini M, Crippa S, Partelli S, Scopelliti F, Tamburrino D, Baldoni A, et al.
World J Gastroenterol
. 2014 Aug;
20(29):10008-23.
PMID: 25110429
Since the first description of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas in the eighties, their identification has dramatically increased in the last decades, hand to hand with the...
6.
Salvia R, Malleo G, Marchegiani G, Pennacchio S, Paiella S, Paini M, et al.
Surgery
. 2012 Jul;
152(3 Suppl 1):S135-42.
PMID: 22766364
Background: Current guidelines for the management of pancreatic cystic neoplasms are based on the assumption that these lesions can be classified correctly on the basis of features of cross-sectional imaging....
7.
Malleo G, Bassi C, Rossini R, Manfredi R, Butturini G, Massignani M, et al.
Gut
. 2011 Sep;
61(5):746-51.
PMID: 21940725
Background And Aims: The natural history and growth pattern of pancreatic serous cystic neoplasms (SCNs) are not well understood. This study was designed in order to get insight into the...
8.
Salvia R, Crippa S, Partelli S, Armatura G, Malleo G, Paini M, et al.
World J Gastrointest Surg
. 2010 Dec;
2(10):342-6.
PMID: 21160841
In the last decade, intraductal papillary mucinous neoplasms (IPMNs) have become commonly diagnosed. From a morphological standpoint, they are classified in main-duct IPMNs (MD-IPMNs) and branch-duct IPMNs (BD-IPMNs), depending on...